GV1001
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The cell-penetrating peptide GV1001 has been investigated as an anticancer agent and recently demonstrated anti-oxidant and anti…
OBJECTIVES
Lung ischaemia-reperfusion (IR) injury is one of the major complications following lung transplantation. The novel…
Background GV1001 is a 16-mer peptide developed as a cancer vaccine to prime the immune system to recognize telomerase. Besides…
Background GV1001 is a 16-mer peptide developed as a cancer vaccine to prime the immune system to recognize telomerase. Besides…